In breast cancer, ACSL4 expression is strongly correlated with ferroptosis sensitivity; in specific basal-like cell lines, ACSL4 promotes PUFA uptake and enhances susceptibility [53,54]. Here, ACSL4 is linked to breast carcinoma.